FDA grants emergency use authorization for Eli Lilly antibody treatment for COVID-19
On Monday, the U.S. Food and Drug Administration granted Emergency Use Authorization for Eli Lilly and Company’s investigational neutralizing antibody bamlanivimab. Bamlanivimab is ...